The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Staff cuts. Furloughs. Realignments of roles and responsibilities. Pivoting to new SOPs and technologies. Remote work as the “new normal.” COVID-19 caused major disruptions in the clinical research workforce.
In this panel session, leadership from sites, sponsors, and CROs will share what they learned while navigating this unprecedented workforce shake-up. They’ll share changes that were thrust upon their teams, what worked, what didn’t – and most importantly, the potential lasting impacts the pandemic is likely to have on the workforce.
Speaker(s):
Abby
Statler,
Director of Research Quality and Safety,
Dartmouth-Hitchcock Medical Center
Jennifer
Sheller,
BS, MPH,
North America Regional Head, Global Clinical Trial Operations,
Merck
Anita Holland
7/13/21 1:05 pm
Great session